AstraZeneca Pharma India Limited

NSE:ASTRAZEN.NS

7972 (INR) • At close May 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20242023202220212020201920182017201620152014201320122011201020092008200720062005
Operating Activities:
Net Income 1,615.11,341830.41,270.91,139.7726.743835552.59-208.397-5.089-702.7292.5481,009.463883.9221,143.76953.489749.511647.761257.503
Depreciation & Amortization 149.4162.6169.5197.5185.8149.2147.4158.3174.264152.815101.249122.78273.38688.12860.76768.76358.39957.30951.94644.156
Deferred Income Tax 00000000000000000000
Stock Based Compensation 27.423.71518.214.811.29.58.67.74.08800000000000
Change In Working Capital -1,281.7-301.9328.9-39.5-26.698.1-342.5-2.4420.949-325.781176.593612.334385.78656.146-233.939-21.977-170.88364.038-133.594178.308
Accounts Receivables -506.231-236.3-47.1-45.7-58.6-281.3-116408431.628123.264-170.07183.40600000002.689
Inventory -376.679-499.948195.853.5-470.3-49.6-554.4190.294.01196.269-103.885-102.722-178.944-220.025-11.937-102.185102.257-88.9166.041226.464
Accounts Payables -313.667374.496.7-313.4414.5552.776.9-449.3000000000000
Other Working Capital -85.12359.94883.5266.187.8-123.7251-151.3-104.69-545.313450.548631.65564.729276.171-222.00280.208-273.14152.954-139.635-50.845
Other Non Cash Items -231.5-642.515-339-395.9-435.9-433.7-163.6-137.6-82.006-75.642-280.829-92.776-364.451-508.727-385.035-374.065-443.942-324.654-285.23629.401
Operating Cash Flow 278.7582.91,0081,047.8874.2549.887.9381569.885-457.005-8.076-60.361387.269645.01325.714816.482397.063546.205280.876509.367
Investing Activities:
Investments In Property Plant And Equipment -107.6-85.2-96.2-77.1-142.2-186.9-62.8-56.5-90.449-238.052-216.337-187.864-398.427-322.747-71.19-48.273-68.423-75.04-77.924-81.14
Acquisitions Net 00000000000000000005.292
Purchases Of Investments 000-1,714.2-1,690-330-110.80000000000000
Sales Maturities Of Investments 0001,6900446.800.100000000.0100.0561.880
Other Investing Activites 325266.3143.61,831.6124.2112.98058.954.39151.61370.63731.68561.60245.88993.096100.941.4550.36834.4190
Investing Cash Flow 217.4181.147.41,730.3-1,70842.8-93.62.5-36.058-186.439-145.7-156.178-336.825-276.85821.90652.637-26.973-24.617-41.624-75.848
Financing Activities:
Debt Repayment 00000000-2.7520-0.1610-0.5170000000
Common Stock Issued 00000000000000000000
Common Stock Repurchased 00000000000000000000
Dividends Paid -400-200-50-50-25000000-89.096-249.604-249.318-373.884-371.483-297.666-99.019-247.33-19.475
Other Financing Activities -43.8-44.8-44.6-39.7-38.600-2.157-2.3950862.387-14.188-40.598-41.607-734.941-169.95-42.075-14.025-32.672-2.498
Financing Cash Flow -443.8-244.8-94.6-89.7-63.600-2.157-5.1460862.226-103.284-290.719-290.925-1,108.826-541.433-339.741-113.044-280.002-21.973
Other Information:
Effect Of Forex Changes On Cash 00000000000000000000
Net Change In Cash 52.3519.2960.82,688.4-897.4592.6-5.7383.459528.681-643.444708.45-319.823-240.27577.228-761.205327.68530.35408.544-40.750
Cash At End Of Period 5,055.75,003.44,484.23,523.48351,732.41,139.81,145.5762.006233.325876.77168.32488.143728.418676.8341,438.0391,110.3551,080.005671.46143.534